Gene · 406921
Papers4,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 3D Culture and Interferon-γ Priming Modulates Characteristics of Mesenchymal Stromal/Stem Cells by Modifying the Expression of Both Intracellular and Exosomal microRNAs. | Biology (Basel) | 2023 | 37626949 | PubTator, text mining | PubMed |
| Drug Discovery and Development of miRNA-Based Nucleotide Drugs for Gastrointestinal Cancer. | Biomedicines | 2023 | 37626731 | PubTator, text mining | PubMed |
| Clinical Theragnostic Signature of Extracellular Vesicles in Traumatic Brain Injury (TBI). | ACS Chem Neurosci | 2023 | 37624044 | PubTator, text mining | PubMed |
| Identifying potential circulating miRNA biomarkers for the diagnosis and prediction of ovarian cancer using machine-learning approach: application of Boruta. | Front Digit Health | 2023 | 37621964 | PubTator, text mining | PubMed |
| A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte. | Front Mol Neurosci | 2023 | 37621405 | PubTator, text mining | PubMed |
| Potential roles of NEDD4 and NEDD4L and their utility as therapeutic targets in high‑incidence adult male cancers (Review). | Mol Clin Oncol | 2023 | 37614371 | PubTator, text mining | PubMed |
| A swift expanding trend of extracellular vesicles in spinal cord injury research: a bibliometric analysis. | J Nanobiotechnology | 2023 | 37612689 | PubTator, text mining | PubMed |
| Corrigendum: miR-212/132-enriched extracellular vesicles promote differentiation of induced pluripotent stem cells into pancreatic beta cells. | Front Cell Dev Biol | 2023 | 37601100 | PubTator, text mining | PubMed |
| MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers. | Cancer Cell Int | 2023 | 37587481 | PubTator, text mining | PubMed |
| The role of miRNAs carried by extracellular vesicles in type 2 diabetes and its complications. | J Diabetes | 2023 | 37583355 | PubTator, text mining | PubMed |
| Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives. | Front Bioeng Biotechnol | 2023 | 37576994 | PubTator, text mining | PubMed |
| Recent advances microRNAs and metabolic reprogramming in colorectal cancer research. | Front Oncol | 2023 | 37576895 | PubTator, text mining | PubMed |
| Roles of Non-Coding RNA in Alzheimer's Disease Pathophysiology. | Int J Mol Sci | 2023 | 37569871 | PubTator, text mining | PubMed |
| Dysregulated Signalling Pathways Driving Anticancer Drug Resistance. | Int J Mol Sci | 2023 | 37569598 | PubTator, text mining | PubMed |
| Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis. | Int J Mol Sci | 2023 | 37569574 | PubTator, text mining | PubMed |
| Lipopolysaccharide Tolerance in Human Primary Monocytes and Polarized Macrophages. | Int J Mol Sci | 2023 | 37569572 | PubTator, text mining | PubMed |
| Oral Spirochete Treponema denticola Intraoral Infection Reveals Unique miR-133a, miR-486, miR-126-3p, miR-126-5p miRNA Expression Kinetics during Periodontitis. | Int J Mol Sci | 2023 | 37569480 | PubTator, text mining | PubMed |
| Unraveling the Complex Web of Mechanistic Regulation of Versatile NEDD4 Family by Non-Coding RNAs in Carcinogenesis and Metastasis: From Cell Culture Studies to Animal Models. | Cancers (Basel) | 2023 | 37568787 | PubTator, text mining | PubMed |
| Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice. | Cancers (Basel) | 2023 | 37568746 | PubTator, text mining | PubMed |
| Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy. | J Clin Med | 2023 | 37568462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/papers?page=16